{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:36:04Z","timestamp":1788870964583,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Agencia Espa\u00f1ola del Medicamento and Fondo de Investigaci\u00f3n Sanitaria","award":["FIS 07-0980"],"award-info":[{"award-number":["FIS 07-0980"]}]},{"name":"Agencia Espa\u00f1ola del Medicamento and Fondo de Investigaci\u00f3n Sanitaria","award":["SAS PI 0082\/207"],"award-info":[{"award-number":["SAS PI 0082\/207"]}]},{"name":"Agencia Espa\u00f1ola del Medicamento and Fondo de Investigaci\u00f3n Sanitaria","award":["PS 09\/01384"],"award-info":[{"award-number":["PS 09\/01384"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jhep.2010.12.041","type":"journal-article","created":{"date-parts":[[2011,2,20]],"date-time":"2011-02-20T04:33:52Z","timestamp":1298176432000},"page":"820-827","source":"Crossref","is-referenced-by-count":89,"title":["Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis"],"prefix":"10.1016","volume":"55","author":[{"given":"M.I.","family":"Lucena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kaplowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hallal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Castiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garc\u00eda-Bengoechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Otazua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Planas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.12.041_b0005","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gut.2008.163675","article-title":"Diagnosis, management and prevention of drug-induced liver injury","volume":"58","author":"Verma","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.12.041_b0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0029-1240008","article-title":"Biomarkers for the diagnosis and management of drug-induced liver injury","volume":"29","author":"Watkins","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2010.12.041_b0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1517\/14740338.2.3.249","article-title":"Antidepressant-induced hepatotoxicity","volume":"2","author":"Lucena","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jhep.2010.12.041_b0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/106002809202600607","article-title":"Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity","volume":"26","author":"Hagley","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jhep.2010.12.041_b0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.295.6591.180","article-title":"Cross hepatotoxicity between non-steroidal anti-inflammatory drugs","volume":"295","author":"Andrejak","year":"1987","journal-title":"Br Med J"},{"key":"10.1016\/j.jhep.2010.12.041_b0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/14740338.2.6.581","article-title":"Hepatotoxicity of thiazolidinediones","volume":"2","author":"Isley","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jhep.2010.12.041_b0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1086\/521174","article-title":"Lack of cross-hepatotoxicity between voriconazole and posaconnazole","volume":"45","author":"Foo","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2010.12.041_b0040","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(99)00569-3","article-title":"Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin","volume":"353","author":"Nakad","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.12.041_b0215","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1200\/JCO.2009.26.5496","article-title":"Successful Treatment With Erlotinib After Gefitinib-Related Severe Hepatotoxicity","volume":"28","author":"Takeda","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2010.12.041_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-8278(94)80259-9","article-title":"Amoxycillin\u2013clavulanic acid\u2013erythromycin cross-liver toxicity: a case report","volume":"21","author":"Horsmans","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.12.041_b0055","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","article-title":"Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex","volume":"49","author":"Lucena","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.12.041_b0060","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs. II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"Benichou","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jhep.2010.12.041_b0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.12.041_b0070","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.12.041_b0075","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.12.041_b0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.12.041_b0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","article-title":"Hy\u2019s law predicting serious hepatotoxicity","volume":"15","author":"Temple","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jhep.2010.12.041_b0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0198-8859(00)00234-2","article-title":"Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus","volume":"62","author":"Goldberg","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2010.12.041_b0095","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1478-3231.2007.01549.x","article-title":"Suspected cross-hepatotoxicity of flutamide and cyproterone acetate","volume":"27","author":"Miquel","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2010.12.041_b0220","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2010.12.041_b0105","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1081-1206(10)61103-9","article-title":"Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents","volume":"97","author":"Seitz","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jhep.2010.12.041_b0110","first-page":"373","article-title":"Cross hepatotoxicity between tricyclic antidepressants and phenothiazines","volume":"7","author":"Remy","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.12.041_b0115","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/0016-5085(92)91453-B","article-title":"Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine","volume":"103","author":"Hautekeete","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.12.041_b0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0090-9556(25)06888-6","article-title":"Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane","volume":"16","author":"Christ","year":"1988","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2010.12.041_b0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(00)80417-1","article-title":"Drug-induced liver diseases","volume":"32","author":"Larrey","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.12.041_b0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.12.041_b0135","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archderm.140.12.1537","article-title":"Moxifloxacin associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure","volume":"140","author":"Nori","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jhep.2010.12.041_b0140","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2217\/pgs.09.111","article-title":"Drug-induced liver injury: insights from genetic studies","volume":"10","author":"Andrade","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jhep.2010.12.041_b0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7 and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.12.041_b0150","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2010.12.041_b0230","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.12.041_b0160","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1345\/aph.1a003","article-title":"History of drug-induced hepatitis and risk of amoxicillin\/clavulanate-induced hepatotoxicity","volume":"35","author":"Schey","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jhep.2010.12.041_b0165","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genowe wide study identifies HLA alleles associated with lumiracoxib-related liver injury","volume":"42","author":"Singer","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2010.12.041_b0170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1183\/09031936.00094409","article-title":"Liver toxicity: the Achilles\u2019 heel of endothelin receptor antagonist therapy?","volume":"34","author":"Hoeper","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhep.2010.12.041_b0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00002018-200730090-00006","article-title":"Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma","volume":"30","author":"Watkins","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2010.12.041_b0180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/313680","article-title":"Trovafloxacin-induced acute hepatitis","volume":"30","author":"Lucena","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2010.12.041_b0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00002018-200528040-00006","article-title":"Hepatic findings in long-term clinical trials of ximelagatran","volume":"28","author":"Lee","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2010.12.041_b0190","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.22272","article-title":"Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals","volume":"47","author":"Lammert","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.12.041_b0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1665-2681(19)32081-2","article-title":"Current concepts in autoimmune hepatitis","volume":"4","author":"Czaja","year":"2005","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2010.12.041_b0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2008.10.021","article-title":"The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice","volume":"50","author":"Bj\u00f6rnsson","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.12.041_b0205","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.12.041_b0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0029-1240010","article-title":"Drug-induced liver injury associated with statins","volume":"29","author":"Russo","year":"2009","journal-title":"Semin Liver Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811001711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811001711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T15:42:25Z","timestamp":1740930145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827811001711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0168827811001711"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.12.041","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}